Literature DB >> 15885125

The Vgamma2/Vdelta2 T-cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vgamma2/Jgamma1.2 subset.

Cristiana Cairo1, Nadia Propp, Andrew M Hebbeler, Vittorio Colizzi, C David Pauza.   

Abstract

Circulating Vgamma2/Vdelta2 T cells in human and non-human primates respond to small molecular weight non-peptidic phosphoantigens in a major histocompatibility complex (MHC)-unrestricted manner. These responses are encoded by the Vgamma2/Jgamma1.2 chain of the T-cell receptor and are positively selected during early development to create a biased repertoire in adults. We characterized the Vgamma2 chain in cynomolgus macaques (Macaca fascicularis) to develop a non-human primate model for studying the effects of infection and therapy on the circulating Vgamma2/Vdelta2 T-cell subset. The cynomolgus macaque Vgamma2 chain was highly homologous to the Vgamma2 chain from human beings and rhesus macaques (Macaca mulatta), though we noted conserved substitutions in critical residues within the CDR3 for both macaque species. Despite these substitutions, Vgamma2/Vdelta2+ T cells from cynomolgus monkeys exhibited polyclonal responses to two different phosphoantigens. Proliferative responses were observed with both isopentenylpyrophosphate and alendronate, but stronger interferon-gamma secretory responses were observed with isopentenylpyrophosphate. In vitro stimulation and expansion led to selective outgrowth of the Vgamma2/Jgamma1.2 subset, with a marked shift in the Vgamma2 spectratype. As a result of the less biased starting repertoire for Vgamma2, the cynomolgus macaque constitutes a sensitive model for examining the effects of in vitro or in vivo treatments on the Vgamma2/Vdelta2 T-cell population. Our studies establish the value of cynomolgus macaques as a model for Vgamma2/Vdelta2 T-cell responses to non-peptidic antigens, and further evidence the remarkable evolutionary conservation of this unusual, phosphoantigen-responsive T-cell subset that is found only in primate species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885125      PMCID: PMC1782144          DOI: 10.1111/j.1365-2567.2005.02153.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria.

Authors:  C A Daubenberger; M Salomon; W Vecino; B Hübner; H Troll; R Rodriques; M E Patarroyo; G Pluschke
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

2.  Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.

Authors:  H Sicard; T Al Saati; G Delsol; J J Fournié
Journal:  Mol Med       Date:  2001-10       Impact factor: 6.354

3.  Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors.

Authors:  F Davodeau; M A Peyrat; M M Hallet; J Gaschet; I Houde; R Vivien; H Vie; M Bonneville
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

4.  Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells.

Authors:  Hong Wang; Hoi K Lee; Jack F Bukowski; Hongmin Li; Roy A Mariuzza; Zheng W Chen; Ki-Hoan Nam; Craig T Morita
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

Review 5.  Microbial isoprenoid biosynthesis and human gammadelta T cell activation.

Authors:  Matthias Eberl; Martin Hintz; Armin Reichenberg; Ann-Kristin Kollas; Jochen Wiesner; Hassan Jomaa
Journal:  FEBS Lett       Date:  2003-06-05       Impact factor: 4.124

6.  Gamma delta T lymphocytes in human tuberculosis.

Authors:  P F Barnes; C L Grisso; J S Abrams; H Band; T H Rea; R L Modlin
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

7.  Gamma delta T cells and the immune response in visceral leishmaniasis.

Authors:  S Raziuddin; A W Telmasani; M el-Hag el-Awad; O al-Amari; M al-Janadi
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

8.  Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection.

Authors:  A Bertotto; R Gerli; F Spinozzi; C Muscat; F Scalise; G Castellucci; M Sposito; F Candio; R Vaccaro
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

9.  Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.

Authors:  V Malkovska; F K Cigel; N Armstrong; B E Storer; R Hong
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

10.  Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells.

Authors:  Hans-Jürgen Gober; Magdalena Kistowska; Lena Angman; Paul Jenö; Lucia Mori; Gennaro De Libero
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  6 in total

1.  Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.

Authors:  Andrew M Hebbeler; Cristiana Cairo; Jean Saville Cummings; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2006-11-28       Impact factor: 6.968

2.  Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public V gamma 2 repertoire in Macaca fascicularis.

Authors:  Cristiana Cairo; Andrew M Hebbeler; Nadia Propp; Joseph L Bryant; Vittorio Colizzi; C David Pauza
Journal:  Tuberculosis (Edinb)       Date:  2007-02-09       Impact factor: 3.131

3.  Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.

Authors:  Alanna S Murday; Suchita Chaudhry; C David Pauza
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

Review 4.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

5.  Human Vgamma2Vdelta2 T cells contain cytoplasmic RANTES.

Authors:  I Tikhonov; C O Deetz; R Paca; S Berg; V Lukyanenko; J K Lim; C D Pauza
Journal:  Int Immunol       Date:  2006-06-01       Impact factor: 4.823

6.  Human cord blood γδ T cells expressing public Vγ2 chains dominate the response to bisphosphonate plus interleukin-15.

Authors:  Cristiana Cairo; Bertrand Sagnia; Giulia Cappelli; Vittorio Colizzi; Rose G F Leke; Robert J Leke; C David Pauza
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.